sooty mangabey
Recently Published Documents


TOTAL DOCUMENTS

78
(FIVE YEARS 1)

H-INDEX

24
(FIVE YEARS 0)

Primates ◽  
2020 ◽  
Vol 61 (3) ◽  
pp. 357-363
Author(s):  
Maria Joana Ferreira da Silva ◽  
Christina Paddock ◽  
Federica Gerini ◽  
Filipa Borges ◽  
Isa Aleixo-Pais ◽  
...  

2018 ◽  
Vol 301 (2) ◽  
pp. 325-342 ◽  
Author(s):  
Andrea B. Taylor ◽  
Claire E. Terhune ◽  
Maxx Toler ◽  
Megan Holmes ◽  
Callum F. Ross ◽  
...  

Nature ◽  
2018 ◽  
Vol 553 (7686) ◽  
pp. 77-81 ◽  
Author(s):  
David Palesch ◽  
Steven E. Bosinger ◽  
Gregory K. Tharp ◽  
Thomas H. Vanderford ◽  
Mirko Paiardini ◽  
...  

Virology ◽  
2017 ◽  
Vol 510 ◽  
pp. 175-184 ◽  
Author(s):  
Kimberly Schmitt ◽  
Dipu Mohan Kumar ◽  
James Curlin ◽  
Leila Remling-Mulder ◽  
Mark Stenglein ◽  
...  

Oryx ◽  
2017 ◽  
Vol 53 (4) ◽  
pp. 774-781 ◽  
Author(s):  
Anna Binczik ◽  
Paula Roig-Boixeda ◽  
Eckhard W. Heymann ◽  
Matthias Waltert

AbstractHabitat loss and fragmentation, hunting pressure, and human–wildlife conflict threaten the survival of primates across Africa. Particularly dramatic forest losses have occurred outside protected areas in the Guinean forest–savannah transition zone. Using the Boé region, Guinea-Bissau, as a case study, we investigated whether and how this rapidly humanized mosaic of wooded savannah, gallery forests and cropland could sustain viable primate populations. We conducted line transect surveys and reconnaissance (recce) walks to assess populations of one Critically Endangered (chimpanzee Pan troglodytes verus), one Endangered (Temminck's red colobus Piliocolobus badius temminckii), one Vulnerable (king colobus Colobus polykomos), and one Near Threatened (sooty mangabey Cercocebus atys) arboreal primates across a 104 km2 section of Boé in the dry season of 2016. Using the standing crop nest count method we estimated a relatively high chimpanzee density (0.77 individuals per km2, 95% CI 0.45–1.34). An assessment of habitat selection showed that chimpanzees prefer semi-dense forest and fallow fields with remnant old trees for nesting, and locations close to rivers. The other primates studied occurred in extremely low densities and were largely restricted to gallery forests. Our results indicate a need for immediate action to ensure the long-term survival of the primate community in the human-dominated landscape of Boé. Our recommendations include action to maintain hunting pressure at a low level, restoring and protecting gallery forests, introducing incentives for farmers for forest protection and primate-friendly practices, and extending the conservation programme to all arboreal primates in the region.


2017 ◽  
Vol 91 (18) ◽  
Author(s):  
Christoph H. Fellinger ◽  
Matthew R. Gardner ◽  
Charles C. Bailey ◽  
Michael Farzan

ABSTRACT Rhesus macaques are used to model human immunodeficiency virus type 1 (HIV-1) infections, but they are not natural hosts of HIV-1 or any simian immunodeficiency virus (SIV). Rather, they became infected with SIV through cross-species transfer from sooty mangabeys in captivity. It has been shown that HIV-1 utilizes rhesus CD4 less efficiently than human CD4. However, the relative ability of SIV envelope glycoproteins to bind or utilize these CD4 orthologs has not been reported. Here we show that several SIV isolates, including SIVmac239, are more efficiently neutralized by human CD4-Ig (huCD4-Ig) than by the same molecule bearing rhesus CD4 domains 1 and 2 (rhCD4-Ig). An I39N mutation in CD4 domain 1, present in human and sooty mangabey CD4 orthologs, largely restored rhCD4-Ig neutralization of SIVmac239 and other SIV isolates. We further observed that SIVmac316, a derivative of SIVmac239, bound to and was neutralized by huCD4-Ig and rhCD4-Ig with nearly identical efficiencies. Introduction of two SIVmac316 CD4-binding site residues (G382R and H442Y) into the SIVmac239 envelope glycoprotein (Env) markedly increased its neutralization sensitivity to rhesus CD4-Ig without altering neutralization by human CD4-Ig, SIV neutralizing antibodies, or sera from SIV-infected macaques. These changes also allowed SIVmac239 Env to bind rhCD4-Ig more efficiently than huCD4-Ig. The variant with G382R and H442Y (G382R/H442Y variant) also infected cells expressing rhesus CD4 with markedly greater efficiency than did unaltered SIVmac239 Env. We propose that infections of rhesus macaques with SIVmac239 G382R/H442Y might better model some aspects of human infections. IMPORTANCE Rhesus macaque infection with simian immunodeficiency virus (SIV) has served as an important model of human HIV-1 infection. However, differences between this model and the human case have complicated the development of vaccines and therapies. Here we report the surprising observation that SIVmac239, a commonly used model virus, more efficiently utilizes human CD4 than the CD4 of rhesus macaques, whereas the closely related virus SIVmac316 uses both CD4 orthologs equally well. We used this insight to generate a form of SIVmac239 envelope glycoprotein (Env) that utilized rhesus CD4 more efficiently, while retaining its resistance to antibodies and sera from infected macaques. This Env can be used to make the rhesus model more similar in some ways to human infection, for example by facilitating infection of cells with low levels of CD4. This property may be especially important to efforts to eradicate latently infected cells.


2017 ◽  
Vol 114 (10) ◽  
pp. 2729-2734 ◽  
Author(s):  
Hanna-Mari Baldauf ◽  
Lena Stegmann ◽  
Sarah-Marie Schwarz ◽  
Ina Ambiel ◽  
Maud Trotard ◽  
...  

Early after entry into monocytes, macrophages, dendritic cells, and resting CD4 T cells, HIV encounters a block, limiting reverse transcription (RT) of the incoming viral RNA genome. In this context, dNTP triphosphohydrolase SAM domain and HD domain-containing protein 1 (SAMHD1) has been identified as a restriction factor, lowering the concentration of dNTP substrates to limit RT. The accessory lentiviral protein X (Vpx) proteins from the major simian immunodeficiency virus of rhesus macaque, sooty mangabey, and HIV-2 (SIVsmm/SIVmac/HIV-2) lineage packaged into virions target SAMHD1 for proteasomal degradation, increase intracellular dNTP pools, and facilitate HIV cDNA synthesis. We find that virion-packaged Vpx proteins from a second SIV lineage, SIV of red-capped mangabeys or mandrills (SIVrcm/mnd-2), increased HIV infection in resting CD4 T cells, but not in macrophages, and, unexpectedly, acted in the absence of SAMHD1 degradation, dNTP pool elevation, or changes in SAMHD1 phosphorylation. Vpx rcm/mnd-2 virion incorporation resulted in a dramatic increase of HIV-1 RT intermediates and viral cDNA in infected resting CD4 T cells. These analyses also revealed a barrier limiting HIV-1 infection of resting CD4 T cells at the level of nuclear import. Single amino acid changes in the SAMHD1-degrading Vpx mac239 allowed it to enhance early postentry steps in a Vpx rcm/mnd-2–like fashion. Moreover, Vpx enhanced HIV-1 infection of SAMHD1-deficient resting CD4 T cells of a patient with Aicardi-Goutières syndrome. These results indicate that Vpx, in addition to SAMHD1, overcomes a previously unappreciated restriction for lentiviruses at the level of RT that acts independently of dNTP concentrations and is specific to resting CD4 T cells.


2016 ◽  
Vol 90 (24) ◽  
pp. 11087-11095 ◽  
Author(s):  
Fan Wu ◽  
Andrea Kirmaier ◽  
Ellen White ◽  
Ilnour Ourmanov ◽  
Sonya Whitted ◽  
...  

ABSTRACT TRIM5α polymorphism limits and complicates the use of simian immunodeficiency virus (SIV) for evaluation of human immunodeficiency virus (HIV) vaccine strategies in rhesus macaques. We previously reported that the TRIM5α-sensitive SIV from sooty mangabeys (SIVsm) clone SIVsmE543-3 acquired amino acid substitutions in the capsid that overcame TRIM5α restriction when it was passaged in rhesus macaques expressing restrictive TRIM5α alleles. Here we generated TRIM5α-resistant clones of the related SIVsmE660 strain without animal passage by introducing the same amino acid capsid substitutions. We evaluated one of the variants in rhesus macaques expressing permissive and restrictive TRIM5α alleles. The SIVsmE660 variant infected and replicated in macaques with restrictive TRIM5α genotypes as efficiently as in macaques with permissive TRIM5α genotypes. These results demonstrated that mutations in the SIV capsid can confer SIV resistance to TRIM5α restriction without animal passage, suggesting an applicable method to generate more diverse SIV strains for HIV vaccine studies. IMPORTANCE Many strains of SIV from sooty mangabey monkeys are susceptible to resistance by common rhesus macaque TRIM5α alleles and result in reduced virus acquisition and replication in macaques that express these restrictive alleles. We previously observed that spontaneous variations in the capsid gene were associated with improved replication in macaques, and the introduction of two amino acid changes in the capsid transfers this improved replication to the parent clone. In the present study, we introduced these mutations into a related but distinct strain of SIV that is commonly used for challenge studies for vaccine trials. These mutations also improved the replication of this strain in macaques with the restrictive TRIM5α genotype and thus will eliminate the confounding effects of TRIM5α in vaccine studies.


2016 ◽  
Vol 90 (22) ◽  
pp. 10193-10208 ◽  
Author(s):  
Zeli Zhang ◽  
Qinyong Gu ◽  
Ananda Ayyappan Jaguva Vasudevan ◽  
Manimehalai Jeyaraj ◽  
Stanislaw Schmidt ◽  
...  

ABSTRACTLentiviruses have evolved the Vif protein to counteract APOBEC3 (A3) restriction factors by targeting them for proteasomal degradation. Previous studies have identified important residues in the interface of human immunodeficiency virus type 1 (HIV-1) Vif and human APOBEC3C (hA3C) or human APOBEC3F (hA3F). However, the interaction between primate A3C proteins and HIV-1 Vif or natural HIV-1 Vif variants is still poorly understood. Here, we report that HIV-1 Vif is inactive against A3Cs of rhesus macaques (rhA3C), sooty mangabey monkeys (smmA3C), and African green monkeys (agmA3C), while HIV-2, African green monkey simian immunodeficiency virus (SIVagm), and SIVmac Vif proteins efficiently mediate the depletion of all tested A3Cs. We identified that residues N/H130 and Q133 in rhA3C and smmA3C are determinants for this HIV-1 Vif-triggered counteraction. We also found that the HIV-1 Vif interaction sites in helix 4 of hA3C and hA3F differ. Vif alleles from diverse HIV-1 subtypes were tested for degradation activities related to hA3C. The subtype F-1 Vif was identified to be inactive for degradation of hA3C and hA3F. The residues that determined F-1 Vif inactivity in the degradation of A3C/A3F were located in the C-terminal region (K167 and D182). Structural analysis of F-1 Vif revealed that impairing the internal salt bridge of E171-K167 restored reduction capacities to A3C/A3F. Furthermore, we found that D101 could also form an internal interaction with K167. Replacing D101 with glycine and R167 with lysine in NL4-3 Vif impaired its counteractivity to A3F and A3C. This finding indicates that internal interactions outside the A3 binding region in HIV-1 Vif influence the capacity to induce degradation of A3C/A3F.IMPORTANCEThe APOBEC3 restriction factors can serve as potential barriers to lentiviral cross-species transmissions. Vif proteins from lentiviruses counteract APOBEC3 by proteasomal degradation. In this study, we found that monkey-derived A3C, rhA3C and smmA3C, were resistant to HIV-1 Vif. This was determined by A3C residues N/H130 and Q133. However, HIV-2, SIVagm, and SIVmac Vif proteins were found to be able to mediate the depletion of all tested primate A3C proteins. In addition, we identified a natural HIV-1 Vif (F-1 Vif) that was inactive in the degradation of hA3C/hA3F. Here, we provide for the first time a model that explains how an internal salt bridge of E171-K167-D101 influences Vif-mediated degradation of hA3C/hA3F. This finding provides a novel way to develop HIV-1 inhibitors by targeting the internal interactions of the Vif protein.


Sign in / Sign up

Export Citation Format

Share Document